No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Asthmatic Agents / administration & dosage*
-
Asthma / drug therapy
-
Asthma / genetics
-
Drug Evaluation, Preclinical / veterinary
-
Humans
-
Interleukin-13 / antagonists & inhibitors*
-
Interleukin-4 Receptor alpha Subunit / genetics*
-
Interleukin-4* / analogs & derivatives
-
Interleukin-4* / antagonists & inhibitors
-
Macaca fascicularis
-
Pharmacogenetics
-
Polymorphism, Single Nucleotide*
-
Predictive Value of Tests
-
Treatment Outcome
Substances
-
Anti-Asthmatic Agents
-
Interleukin-13
-
Interleukin-4 Receptor alpha Subunit
-
Interleukin-4
Associated data
-
ClinicalTrials.gov/NCT00535431